• ياسر كاظم هاشم
  • Yasser Kadhim Hashim
  • تدريسي : كلية الصيدلة
  • Teaching : college of Pharmacy
  • ماجستير صيدلة
  • علوم مختبرية سريرية / ماجستير
  • yasser@esraa.edu.iq
  • yasser_alzwaini@yahoo.com
  • News

    News

    Yasser Kadhim Hashim

    Yasser Kadhim Hashim

    Syllabuses

    Syllabuses

    Syllabuses - 6
    Dep. Step. Sem. code No. Des. Syllabuses
    college of Pharmacy one term 1 HUB0910 3 Human biology
    college of Pharmacy one term 2 HIS0910 3 Histology
    college of Pharmacy three term 1 PTE0931 4 Pharmaceutical technology I
    college of Pharmacy three term 2 PHR0931 3 Pharmacology I
    college of Pharmacy five term 1 CLT0950 2 Clinical laboratory training
    college of Pharmacy four term 1 2 Pharmacology II laboratory
    Lectures

    Lectures

    المحاضرات الالكترونية - 24
    year syllabuses Dep. Step Lectures
    2022-2023 Pharmacology II laboratory college of Pharmacy المرحلة الرابعة Lab 3 Barbiturate
    2022-2023 Pharmacology II laboratory college of Pharmacy المرحلة الرابعة Lab 2 -eyes
    2022-2023 Pharmacology II laboratory college of Pharmacy المرحلة الرابعة Routes of administration intro.pptx lab 1
    2022-2023 Pharmacology I college of Pharmacy المرحلة الثالثة Mycobacteria.ppt lec. 7
    2022-2023 Pharmacology I college of Pharmacy المرحلة الثالثة FLUOROQUINOLONES lec.6
    2022-2023 Pharmacology I college of Pharmacy المرحلة الثالثة AMINOGLYCOSIDES lec5
    2022-2023 Pharmacology I college of Pharmacy المرحلة الثالثة tetracycline lec4
    2022-2023 Pharmacology I college of Pharmacy المرحلة الثالثة cephalosporins lec.3
    2022-2023 Pharmacology I college of Pharmacy المرحلة الثالثة antimicrobial therapy lec1
    2022-2023 Pharmaceutical technology I college of Pharmacy المرحلة الثالثة lab 6 Suspension
    2022-2023 Pharmaceutical technology I college of Pharmacy المرحلة الثالثة Pharmaceutical Technology lab5 elixir
    2022-2023 Pharmaceutical technology I college of Pharmacy المرحلة الثالثة lab 4 Spirits
    2022-2023 Pharmaceutical technology I college of Pharmacy المرحلة الثالثة lab3 pharm. tech. Syrup
    2022-2023 Pharmaceutical technology I college of Pharmacy المرحلة الثالثة lab 2 pharm. techno Solutions 2
    2022-2023 Pharmaceutical technology I college of Pharmacy المرحلة الثالثة lab1 pharm. tech. Solutions
    2022-2023 Clinical laboratory training college of Pharmacy المرحلة الخامسة SEROLOGICAL TESTS
    2022-2023 Histology college of Pharmacy المرحلة الاولى respiratory system
    2022-2023 Histology college of Pharmacy المرحلة الاولى Circulatory System
    2022-2023 Histology college of Pharmacy المرحلة الاولى respiratory system
    2022-2023 Histology college of Pharmacy المرحلة الاولى Epithelial Tissues
    2022-2023 Human biology college of Pharmacy المرحلة الاولى tissue
    2022-2023 Human biology college of Pharmacy المرحلة الاولى Digestive System
    2022-2023 Human biology college of Pharmacy المرحلة الاولى transport thorough cell membrane
    2022-2023 Human biology college of Pharmacy المرحلة الاولى Introduction to human biology
    Research

    Research

    2019 Al Mustansiriyah Journal of Pharmaceutical Sciences

    Objective: Metastatic spread of tumor cells to distant organs is the leading cause of mortality from cancer. Although metastatic tumor spread can occur via a different mechanism. lymphangiogenic factors recognized were vascular endothelial growth factor (VEGF)–C and –D, which bind to a tyrosine kinase
    receptor, VEGF receptor (R)–3. Binding affinities to VEGFR-2 receptor increase on the lymphatic and blood endothelium therefore enables both growth factors to also exert lymphangiogenic and angiogenic effects and increased incidence of lymph node metastasis. The aim of this study is to evaluate the VEGF-C protein expression in cervical cancer cells and lymph vessels and found the relationship of this marker with lymphangiogensis of Iraqi cervical cancer samples.
    Method: In this study, expression of VEGF-C was noticed in 55 cervical samples by Immuno-
    histochemistry. 35 cases diagnosed as invasive cervical cancer in addition to 20 normal samples consider as control. Immunohistochemistry was performed and the cytoplasm level of VEGF-C was scored by the percentage of positive cells and intensity.
    Results:
    The present data evaluated the prognostic significance of VEGF-C to cervical cancer, cytoplasm staining was seen in 29 cases (82.9 %) in cervical cancer tissues. Only 4 out of 35 cases (11.4 %) displayed cytoplasmic and nuclear tissue. There is significant difference of VEGF-C staining in lymphatic vessels and cancer cells (χ2= 5.04, p = 0.023*) regarding to positive expression (20/ 57.1%), (25/ 71.4 %) respectively and negative VEGF-C staining 15 (42.9%), 10 (28.6 %) respectively. High positive percentage of VEGF-C expression in cytoplasm of malignant cases in score 2& 3 (25.7%, 45.7 %, P-value= 0.0392 *, 0.029* respectively) as compared to normal cases (15%, 30% respectively). Demographic criteria of patients revealed association with VEGF-C expression patterns. Differentiation Well + moderately and histologic type Squamous carcinoma showed significantly associated with VEGF-C (P=0.0071** & 0.0071** respectively). Positive VEGF-C staining in cancer cells had more lymphatic vessel (17/68 %) as compared to negative cases (3/30 %) with Chi-Square 8.263, p value= 0.0061**. Also, positive VEGF-C staining had more lymph node associated (9/36%) compared to negative cases (1/10 %) with Chi-Square 13.503, p value= 0.0001**.

    2020 Research Journal of Pharmacy and Technology (RJPT)

    Objective: to identify the expression of DNA repair protein apyrimidinic endonuclease 1 (APE1) in samples of Iraqi cervical cancer patients. Method: expression of APE1 was detected in 55 cervical tissue samples by immunohistochemistry, divided into two groups; 35 cases detected as invasive cervical cancer and 20 cases considered as control. Immunohistochemistry was achieved and the nuclear and cytoplasm-nuclear level of APE1 was counted by taking into account the ratio of positive cells and intensity. Results: Present data evaluated the prognostic and alterations in APE1 expression levels according to cervical cancer, nuclear stain was seen in the epithelia of 35 cases (100 %) of cervical tumor tissues. Only 29 out of 35 cases (82.85 %) shown cytoplasmic and nuclear staining with significant difference (P value = 0.00027) between malignant and normal cervical tissue. APE1 high-level expression was (77.1%) and low expression was (22.8 %) in cervical cancer tissues. Age, differentiation and histologic type showed highly significant difference (P= 0.0062, 0.0001 and 0.0001 respectively) between the high and low expression of nuclear APEX1 expression. While lymph vascular invasion (positive vs negative group) showed a significant difference (Chi-Square 4.362, P value = 0.0422*) between the high (16/59.2%) and low (4/50%) nuclear expression of APEX1, while lymph node (positive vs negative group) showed no significant association (P-value= 0.1476) between the high and low expression of nuclear APEX1. Conclusion: The highly positive expression of APE1 results will help Iraqi patients in their early investigation and diagnosis of cervical cancer as good marker for the metastases of their tumor and help researchers to study the lymphangiogensis status of tumor.